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SUMMARY – Pterygium is a multifactorial proliferative pathologic change of bulbar conjunctiva. 
The purpose of this study was to determine the effect of the duration of exposure to solar radiation 
(expressed in years) on the incidence of positive cyclooxygenase-2 (COX-2) finding in conjunctival 
tissue in two groups of patients. Group 1 consisted of 68 patients with primary pterygium having 
undergone conjunctival autograft transplantation. Group 2 consisted of 43 patients with morphologi-
cally unchanged conjunctivae that were harvested during cataract surgery. All 111 specimens were 
submitted to immunohistochemical staining for monoclonal COX-2 antibody (1:100; M361701 MO 
A-HU, Dako, Santa Clara, California, USA). The immunostaining intensity in the surface epithelium 
was scored using the following grading system: 0 no immunostaining; + weak immunostaining (few 
cells being positive focally or scattered); ++ medium immunostaining; and +++ strong immunostaining 
(diffuse staining throughout the tissue). The analysis of COX-2 activity yielded 29 (42.6%) positive 
findings in group 1 and 27 (62.8%) positive findings in group 2. Group 2 consisted of statistically 
significantly older individuals with a history of considerably longer sun exposure. Statistical analysis 
proved the duration of exposure to solar radiation to be the most important factor in positive COX-2 
findings.
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Introduction
Pterygium is a common degenerative, triangular, 
fibrovascular, pathologic change of bulbar conjunctiva, 
which tends to ingrow subepithelially, from the limbus 
toward the centre of the cornea. Clinically, pterygium 
can be divided into four grades by severity of changes 
(grade I, tissue affects the limbus; grade II, tissue on 
the limbus; grade III, tissue between the limbus and 
pupil; and grade IV, tissue extends beyond the pupil). 
It is assumed that different causal factors (inflamma-
tion, infection, ultraviolet (UV) exposure, chemical 
and mechanical irritants, human papilloma viruses)1 
contribute to the development of pterygium. UV ra-
diation2-5 can induce cellular changes in the medial 
parts of the limbus6. Distribution of the incidence is 
related to particular geographical areas7-10. Older age 
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and population living in rural areas are parameters re-
lated to long-term work in open areas and cumulated 
sun exposure, exposure to chemical and mechanical 
 irritants, and chronic dryness of the eye surface. The 
present results suggest a multifactorial pathogenesis of 
pterygium and this study was focused on the inflam-
matory component11,12. Several cytokines such as 
transforming growth factor-β (TGF-β), tumor necro-
sis factor α (TNF-α) and fibroblast growth factor 
(FGF) have been localized in both inflammatory and 
resident cells of pterygia. Kria et al.13 report that pte-
rygium fibroblasts express fibroangiogenic factors such 
as FGF, TGF-β, TNF-α and platelet derived growth 
factor (PDGF), suggesting that they may have a role 
in the pterygium pathogenesis. Cyclooxygenase-2 
(COX-2) is a complex organic molecule classified in 
the group of enzymes, the genesis of which is influ-
enced by different factors (growth factors, mitogens, 
cytokines, and tumor promoters)14. Evidence indicates 
that the COX-2 – prostanoid pathway is involved in 
inflammation15,16. COX-2 modulates angiogenesis by 
increasing the production of angiogenic factors such as 
vascular endothelial growth factor (VEGF). There are 
two types of cyclooxygenase, cyclooxygenase-1 (COX-
1), present in most tissues, and COX-2, a general in-
flammation mediator that is involved in the metabo-
lism of arachidonic acid, one of the modulators of the 
inflammatory response17,18. COX-2 is induced by the 
tumor-promoting factors such as ultraviolet (UV) ra-
diation. In the skin carcinogenesis19-21 related to UV 
radiation, both radical oxygen species (ROS) and 
COX-2 play an important role22. There is an assumed 
direct phototoxic mechanism of UV radiation and an 
indirect mechanism, through the formation of ROS 
(so-called oxidative stress)2, which damages cells and 
induces the synthesis of COX-2, which further stimu-
lates prostaglandin E2 (PGE2). Chiang et al.23 and 
Fischer et al.24 assumed COX-2 to induce the synthe-
sis of PGE2, which acts as a mitogen, and to inhibit 
apoptosis resulting in persistence of the so-called ‘sun-
burn cells’ that would normally degrade by apoptosis in 
the epidermis. This mechanism reduces the ability of 
cells to mask, and they become more exposed to tu-
morigenic factors increasing the accumulation of de-
oxyribonucleic acid (DNA) damage and reducing the 
ability of repairing damaged DNA2,25. Maxia et al.26 
suggest a strong correlation of COX-2 and survivin, a 
protein that is an inhibitor of apoptosis (IAPs), in the 
group of primary pterygia developed by the assumed 
‘anti-apoptotic’ mechanism.
Patients, Materials and Methods
This study included 111 patients treated at the De-
partment of Ophthalmology, Osijek University Hos-
pital Centre. The patients undergoing surgery at the 
Department of Ophthalmology, Osijek University 
Hospital Centre from 2010 to 2013 were divided into 
two groups. Group 1 consisted of patients having un-
dergone 3rd and 4th degree primary pterygium of the 
eye conjunctiva surgery. Group 2 consisted of patients 
having undergone cataract surgery (mainly by phaco-
emulsification), without degenerative changes on the 
conjunctiva. Patients with recurrent pterygium and 
other conjunctival pathology, those with inflammatory 
eye and/or systemic inflammatory disease, and patients 
with any topical therapy (because of therapy side ef-
fects such as hyperemia, effects of preservatives on the 
surface of the eye or immunosuppression effect) were 
excluded from the study due to possible false positive 
findings of COX-2 activity. All patients provided their 
informed consent for participation in the study.
Data were collected through surveys preoperatively 
and postoperatively at regular check-ups (demograph-
ic data, exposure to external conditions, occupation, 
level of education, comorbidities). The surveys were 
applied individually, containing closed-ended ques-
tions and open-ended questions.
During the 3rd and 4th degree primary pterygium 
surgery (group 1), the removed tissue was taken, con-
tinuing the operation routinely. In group 2, the nasal 
bulbar conjunctiva specimen (minimum 3x3 mm) was 
obtained immediately after finishing the cataract sur-
gery, more precisely, at the moment when the eye is 
‘closed’, with the aim of intraoperative risk reduction. 
Apart from the anesthetic, which has no impact on the 
results of the COX-2 analysis, no other medication 
was administered before taking the sample.
All specimens were fixed overnight in 10% buff-
ered formalin before being embedded in paraffin. 
Three-µm thick sections were cut and stained using 
hematoxylin and eosin (H&E). For immunohisto-
chemical staining, all sections were deparaffinized in 
xylene and hydrated in descending dilution of ethanol. 
For the antigen, specimen slides were put in a pre-
heated buffer solution maintaining heat in a water 
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bath (95-99 ºC). The specimen slides were tested with 
COX-2 antibody (1:100; M361701 MO A-HU, Dako, 
Santa Clara, California, USA). Macrophages found in 
mucosa of the small intestine and colon samples with 
proven inflammatory bowel disease were used as posi-
tive control in COX-2 immunostaining, whereas neg-
ative controls were obtained by leaving out primary 
antibody. The intensity of immunostaining in the sur-
face epithelium was scored using the following grad-
ing system: 0 no immunostaining; + weak immunos-
taining (few cells positive focally or scattered); ++ me-
dium immunostaining; and +++ strong immunostain-
ing (diffuse staining throughout the tissue).
Ethics
The study protocol was approved by the institu-
tional Ethics Committee and performed according to 
ethical principles of the 1975 Helsinki Declarations, as 
revised in 1983.
Statistics
Standard descriptive methods were used. Categori-
cal variables were expressed by absolute and relative 
frequencies. Mean values of continuous variables were 
expressed as median and interquartile range. To ex-
plore the difference between the two independent 
groups, Mann-Whitney test was performed, whereas 
differences between categorical variables were tested 
by Fisher exact test. Using the logistic regression 
method, the impact of multiple predictors was assessed 
regarding the possibility of developing COX-2 anti-
bodies in the study subjects. Data were analyzed by 
statistical methods of testing using SPSS 15.0 (SPSS 
Inc., Chicago, IL, USA). The level of statistical signifi-
cance was set at p=0.05.
Results
The study included 111 patients, 68 (61.3%) pa-
tients having undergone primary pterygium surgery 
(group 1) and 43 (38.7%) patients with morphologi-
cally unchanged conjunctiva (group 2). Gender distri-
bution was similar (M:F ratio, 45:66). The mean age of 
patients was 68 (interquartile range 57-77) years, but 
group 2 patients were significantly older (Mann Whit-
ney test, p<0.001) (Table 1). Most of the patients 
(66.7%) lived in rural areas, which is associated with 
lifestyle resulting in greater long-term sun exposure. 
Lower educational levels were recorded in 54 (48.7%) 
of all study patients, without significant between-
group differences (22:32), which affected their lifestyle 
as they were working outdoors more often (agricul-
ture). Working outdoors were forty patients (36%- oc-
cupation related). To sunlight were exposed 87 (78.4%) 
patients with no significant difference between the 
groups. The mean number of years of sun exposure was 
Table 1. Age and sex distribution of patients in control and experimental groups
Parameter value
Control group Experimental group Total p
Sex:
male 14 (32.6) 31 (45.6) 45 (40.5)
0.234*female 29 (67.4) 37 (54.4) 66 (59.5)
Age (years) 77 (66-81) 62 (54-72.8) 68 (57-77) <0.001†
Age group (years):
≤39 0 2 (2.9) 2 (1.8)
<0.001*
40-49 0 7 (10.3) 7 (6.3)
50-59 4 (9.3) 20 (29.4) 24 (21.6)
60-69 9 (20.9) 17 (25) 26 (23.4)
70-79 16 (37.2) 16 (25.5) 32 (28.8)
≥80 14 (32.6) 6 (8.8) 20 (18)
Total 43 (38.7) 68 (61.3) 111 (100)
*Fisher exact test; †Mann Whitney test
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significantly higher (48:22) in group 2 (Mann Whit-
ney test, p<0.001). According to COX-2 analysis, pos-
itive results were found in 56 (50.5%) patients, 29 
(42.6%) of which in group 1 with primary pterygium 
and 27 (62.8%) in group 2 (Table 2).
Positive findings of COX-2 antibodies were sig-
nificant among elderly patients, median age 73.5 (in-
terquartile range 60-79 years; Mann Whitney test, 
p=0.032). The mean number of years of sun exposure 
was 30 years. COX-2 positive findings were signifi-
cantly higher in the group of patients with more years 
of exposure, i.e. 36 (interquartile range 20-52.5) years, 
than in those with negative findings (Mann Whitney 
test, p=0.003). There were no significant gender differ-
ences (Table 3, Figs. 1 and 2).
Logistic regression was used to assess the impact of 
several factors on the likelihood of study patients to 
develop positive COX-2 antibodies. The model con-
tains seven variables that influence positive COX-2 
findings (gender, age, sun exposure duration in years, 
residence (urban or rural), and most common comor-
bidities including arterial hypertension, diabetes mel-
litus, and cardiomyopathy) (Table 4).
As a model, statistically significant predictors 
(χ2=30.15; df=3; p=0.003) were observed (gender, age 
and duration of sun exposure in years), indicating that 
these were capable of differentiating patients accord-
ing to the clinical picture of COX-2 positive findings, 
thus completely explaining 15% (Cox & Snell) to 20% 
(Negelkerke) of variance in the presence of positive 
finding, and accurately classifying 66.7% of cases. The 
strongest predictor was duration of sun exposure in 
years (Table 5).
In group 1, duration of sun exposure could not be 
determined in 13 (19%) patients. In the remaining 55 
(81%) patients, difference in the antibody COX-2 
Table 2. Patient distribution according to residence, education level, occupation, sun exposure and positive vs. 
negative COX-2 findings
Parameter value
Group 2 Group 1 Total p
Residence:
urban 13 (30.2) 24 (35.3) 37 (33.3)
0.542*rural 30 (69.8) 44 (64.7) 74 (66.7)
Level of education:
illiterate 1 (2.3) 1 (1.5) 2 (1.8)
0.656*
low qualification 22 (51.2) 32 (47) 54 (48.7)
high school 17 (39.5) 32 (47) 49 (44.1)
university degree 3 (7) 1 (1.5) 4 (3.6)
elementary school 0 2 (3) 2 (1.8)
Occupation:
outdoor work‡ 15 (34.9) 25 (36.8) 40 (36)
>0.950*indoor work** 24 (55.8) 37 (54.4) 61 (55)
work with chemicals, dust, high temperatures*** 4 (9.3) 6 (8.8) 10 (9)
Sun exposure:
yes 32 (74.4) 55 (80.9) 87 (78.4)
0.481*no 11 (25.6) 13 (19.1) 24 (21.6)
Sun exposure (years) 48 (28.5-59) 22 (5-35) 30 (12-50) <0.001†
COX-2 antibody analysis:
negative 16 (37.2) 39 (57.4) 55 (49.5)
0.175§positive 27 (62.8) 29 (42.6) 56 (50.5)
*Fisher exact test; †Mann Whitney test; §McNemar test; ‡outdoor work: farmers, drivers, loggers, construction workers; **in-
door work: maids, housewives, unemployed, pensioners, crafts related to confined spaces; ***large furnace stokers, bakers, work-
ers in textile and chemical industries
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Table 3. Mean values of gender, age and sun exposure expressed in years according to positive vs. negative COX-2 
antibody analysis
Treatment of COX-2 antibodies
pNegative Positive Total
Gender:
male (%) 17 (30.9) 28 (50) 45 (40.5)
0.053*female (%) 38 (69.1) 28 (50) 66 (59.5)
Age (years) 64 (56-74) 73.5 (60-79) 68 (57-77) 0.032†
Sun exposure (years) 21 (3.9-40) 36 (20-52.5) 30 (12-50) 0.003†
*Fisher exact test; †Mann Whitney test
Fig. 1. COX-2 antibody distribution according to patient 
age (median and interquartile range).
COX-2 = cyclooxygenase 2
Fig. 2. COX-2 antibody distribution according to sun 
exposure expressed in years (median and interquartile range)
COX-2 = cyclooxygenase 2
findings in pterygium tissue (depending on the dura-
tion of sun exposure in years) proved the increase in 
the duration of sun exposure to have led to poorer 
findings (Fisher exact test, p=0.008) (Table 6).
Discussion
Analysis of our study groups showed sun exposure 
duration to be the strongest predictor in assessing the 
probability that patients would develop COX-2 anti-
bodies (p=0.043). Geographical variations in the inci-
dence of diseases such as pterygium have led to theo-
ries pointing at sun exposure as a potential etiologic 
factor7-9. Epidemiologic studies indicate that chronic 
exposure to sunlight, and most probably UV radiation, 
is an important factor in pterygium development10. 
The first international meta-analysis included 20 stud-
ies (English and Chinese) and showed the pooled 
prevalence of pterygium to be relatively high (10.2%), 
especially in low (20°-30°) latitude regions and elderly 
population27. Similarly, the prevalence of pterygium in 
a Tibetan population at high altitude is significantly 
high8. The primary causative factors are related to ocu-
lar sun exposure, which coincides with the results of 
our study. Positive COX-2 was found in a significant 
number of patients that had been exposed to sun for a 
number of years (p=0.003). Group 2 consisted of a sig-
nificantly older population (p=0.032) with a higher 
mean value of sun exposure in years. Therefore, the cu-
mulated effect of sun exposure should have yielded 
more positive COX-2 findings than in group 1 with a 
lower total number of years of sun exposure. The in-
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creasing trend of positive COX-2 findings in older pa-
tients may be explained by the cumulative effect of sun 
exposure. In the international meta-analysis, there was 
a significant trend of greater pterygium prevalence in 
older ages (11% vs. 15.6% vs. 20.1% in 40-49 vs. 50-59 
vs. 60-69 age group, respectively), but the trends were 
generally similar in 60-69 and >70 age groups (20.1% 
vs. 20.2%, respectively)1. COX-2 is the main UV-re-
sponsive COX isoform in human skin and is involved 
in UV-induced skin inflammation and apoptosis (sim-
ilar to the pathogenesis of pterygium)2,25. Diclofenac, a 
topical nonsteroidal anti-inflammatory drug (NSAID), 
acts as a nonspecific COX inhibitor and is an effective 
treatment for actinic keratosis24. Oral and topical 
Table 4. Effect of particular predictors of positive findings on COX-2 prevalence (univariate regression analysis)





Gender -0.804 0.396 4.132 0.042 0.447 0.206-0.972
Age 0.033 0.016 4.304 0.038 1.034 1.002-1.067
Duration of sun exposure (years) 0.034 0.012 8.505 0.004 1.034 1.011-1.058
Residence (urban/rural) 0.274 0.406 0.455 0.500 1.315 0.594-2.912
Arterial hypertension 0.471 0.382 1.518 0.218 1.602 0.757-3.389
Diabetes mellitus -0.442 0.534 0.408 0.408 0.643 0.226-1.832
Cardiomyopathy 0.955 0.859 1.234 0.267 2.598 0.482-14.0
COX-2 = cyclooxygenase 2; 95% CI = 95% confidence interval
Table 5. Predicting the likelihood of patients with positive antibody COX-2 to develop clinical symptoms (multivariate 
regression analysis)





Gender 0.830 0.474 3.069 0.080 2.294 0.906-5.807
Age 0.026 0.021 1.517 0.218 1.026 0.985-1.068
Sun exposure (years) 0.026 0.013 4.097 0.043 1.027 1.001-1.053
Constant -2.760 1.324 4.345 0.037 0.063
COX-2 = cyclooxygenase 2; 95% CI = 95% confidence interval
Table 6. Sun exposure duration in relation to positive COX-2 in pterygium
Sun exposure
(years) 
Number (%) of respondents
p*COX-2 finding in pterygium tissue
Negative +† ++§ +++‡ Total
≤10 16 (48.5) 1/10 1/8 0 18 (32.7)
0.008
11-20 3 (9.1) 3/10 3/8 0 9 (16.4)
21-30 6 (18.2) 1/10 1/8 2/4 10 (18.2)
31-40 5 (15.2) 0 2/8 1/4 8 (14.5)
41-50 1 (3) 2/10 1/8 1/4 5 (9.1)
≥51 2 (6) 3/10 0 0 5 (9.1)
Total 33 (100) 10/10 8/8 4/4 55 (100)
COX-2 = cyclooxygenase 2; *Fisher exact test; †weak immunostaining (few cells positive focally or scattered); 
§medium intensity of immunostaining; ‡strong immunostaining (diffuse staining throughout the tissue)
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COX-2 inhibitors exert chemopreventive activity 
against UV light-induced skin cancer in animal mod-
els. The mechanism of action of COX inhibitors in 
skin tumorigenesis is complex and not completely un-
derstood. This poses new challenges for primary pre-
ventive measures within protection against sun expo-
sure and encourages epidemiologically necessary ac-
tions to educate the population at large. Thus, the 
question of justifying secondary prevention in terms of 
long-term NSAID therapy as COX-2 inhibitors in in-
dividuals with the above-mentioned factors with a 
dominant effect on COX-2 analysis (number of years 
of sun exposure) should be brought up12,28. Park et al.29 
believe that the expression of COX-2 and VEGF in 
macrophages also has an important role in the patho-
genesis of pterygium. This indicates a possibility of 
combined therapy (e.g., NSAID and anti-VEGF). 
Chiang et al.23 investigated the expression of COX-2 
in pterygium and 83.3% of specimens stained positive 
for COX-2 in the pterygium group. In our study, a 
similar positive result of COX-2 activity in both group 
2 and group 1 with primary pterygium excluded in-
flammation as the only cause of pterygium. Literature 
search also suggests its multifactorial origin11,12.
Conclusions
As our group 2 included significantly older pa-
tients, they had more positive findings of COX-2 anti-
body expression (p=0.032). The patients having a his-
tory of longer sun exposure (expressed in years) were 
more often positive for COX-2 (p=0.003). The dura-
tion of sun exposure influenced the severity of findings 
in pterygium tissue, which positively correlated with 
the intensity of COX-2 activity in pterygium tissue 
(p=0.008). Considering gender, age and duration of 
sun exposure as predictors of how each of them af-
fected the findings, duration of sun exposure was dem-
onstrated to be the strongest predictor.
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Sažetak
UTJECAJ TRAJANJA SUNČEVE IZLOŽENOSTI NA AKTIVNOST CIKLOOKSIGENAZE 2  
U TKIVIMA SPOJNICE
P. Reisz Majić, B. Cerovski, P. Majić, I. Krković, J. Barać i I. Bradvica Štenc
Pterigij je multifaktorijalna proliferativna promjena bulbarne spojnice. Svrha rada bila je ustanoviti utjecaj duljine trajanja 
solarne ekspozicije (u godinama) na incidenciju pozitivnih nalaza aktivnosti ciklooksigenaze 2 (COX-2) u dvjema skupina-
ma tkiva spojnica. Prvu skupinu činilo je 68 operiranih bolesnika s primarnim pterigijem metodom autotransplantacije 
spojnice. Drugu skupinu činile su morfološki nepromijenjene spojnice 43 bolesnika operiranih zbog katarakte. Ukupno 111 
uzoraka spojnice je imunohistokemijski analizirano pomoću monoklonskih antitijela COX-2 (1:100; M361701 MO A-HU, 
Dako). Analiza aktivnosti COX-2 spojnica pokazala je u prvoj skupini 29 (42,6%), a u drugoj skupini 27 (62,8%) pozitivnih 
nalaza. Druga skupina bila je statistički značajno starija i sa značajno većom duljinom solarne ekspozicije. Statističkom ana-
lizom dokazala se duljina solarne ekspozicije kao najznačajniji čimbenik za pozitivnost nalaza COX-2.
Ključne riječi: Konjunktiva; Ciklooksigenaza 2; Pterigij; Sunčeva svjetlost – štetno djelovanje
